Fludarabine phosphate (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Fludarabine phosphate drug offered from Actavis Pharma, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Fludarabine phosphate
SUBSTANCE NAME: FLUDARABINE PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-01-05
END MARKETING DATE: 0000-00-00


Fludarabine phosphate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFludarabine phosphate from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/2mL)
START MARKETING DATE: 2015-01-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 45963-609_75709606-99c0-48c4-9674-7342de1815c6
PRODUCT NDC: 45963-609
APPLICATION NUMBER: ANDA078610

Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Fludarabine phosphate
APP Pharmaceuticals, LLCFludarabine
Fresenius Kabi USA, LLCFludarabine
Hospira, Inc.Fludarabine Phosphate
Mylan Institutional LLCFludarabine Phosphate
Pfizer Laboratories Div Pfizer Inc.Fludarabine Phosphate
Sagent PharmaceuticalsFludarabine Phosphate
Sandoz IncFludarabine Phosphate
Teva Parenteral Medicines, Inc.Fludarabine Phosphate